Kyrgyzstan META data disclosure challenges

•Transferir como PPT, PDF•

0 gostou•362 visualizações

Presentation by Suluke Abakirova, National META Secretariat, Kyrgyzstan during the MeTA countries sharing meeting, London 2009.

Saúde e medicina Negócios Tecnologia

Suluke Abakirova National META Secretariat Data Disclosure in Kyrgyzstan MeTA 18/01/10

Type of data being collected ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Type of data being collected ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Overview of disclosure process and engagement of stakeholders (Stakeholders involvement) ,[object Object],[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Lessons Learned ,[object Object],[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Main challenges ,[object Object],[object Object],[object Object]

Type of support needed ,[object Object],[object Object],[object Object],18/01/10 MeTA

Thank you! ,[object Object],[object Object],[object Object],18/01/10 MeTA

Mais conteúdo relacionado

Mais procurados

TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Australia

Presentation: CMA Advertising SeminarTGA Australia

Periodic Safety Update Report (PSUR)Dr. Rohith K Nair

safety-aggregate-reporting-and-analytics-aagSaba Anwer, MPH, MBA

WHO Contribution to impementing MeTAMeTApresents

Update on regulatory reforms from the Scientific Evaluation BranchTGA Australia

Literature monitoring for pv what are we doing at galderma elsevier webinarAnn-Marie Roche

Presentation: Advertising therapeutic goods to consumers TGA Australia

From Research to Public Service: What do scientists and engineers do at the TGATGA Australia

Presentation: Prescription Medicines ReformsTGA Australia

Presentation: Spotlight on prescription medicine post-market reformsTGA Australia

The importance of post-marketing registries for payers and regulators to mana...3GDR

Periodic Safety Update Reports: Some commonly asked questionsTGA Australia

Presentation: What’s new in the 2019 RMP guidance update?TGA Australia

Presentation: Updates from the Therapeutic Goods Administration - For medicin...TGA Australia

Road towards GVP VII Rev II - Explanatory note updatesDr. Rohith K Nair

Manufacturing Investigational Medicinal Products - Legislative and GMP requir...TGA Australia

General principles of Periodic Safety Update Reports(PSUR)Psur by Julia Appel...László Árvai

Presentation: A spotlight on other reforms from the medicines and medical dev...TGA Australia

Presentation: Spotlight on medical device MMDR reformsTGA Australia

Mais procurados (20)

TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018

Presentation: CMA Advertising Seminar

Periodic Safety Update Report (PSUR)

safety-aggregate-reporting-and-analytics-aag

WHO Contribution to impementing MeTA

Update on regulatory reforms from the Scientific Evaluation Branch

Literature monitoring for pv what are we doing at galderma elsevier webinar

Presentation: Advertising therapeutic goods to consumers

From Research to Public Service: What do scientists and engineers do at the TGA

Presentation: Prescription Medicines Reforms

Presentation: Spotlight on prescription medicine post-market reforms

The importance of post-marketing registries for payers and regulators to mana...

Periodic Safety Update Reports: Some commonly asked questions

Presentation: What’s new in the 2019 RMP guidance update?

Presentation: Updates from the Therapeutic Goods Administration - For medicin...

Road towards GVP VII Rev II - Explanatory note updates

Manufacturing Investigational Medicinal Products - Legislative and GMP requir...

General principles of Periodic Safety Update Reports(PSUR)Psur by Julia Appel...

Presentation: A spotlight on other reforms from the medicines and medical dev...

Presentation: Spotlight on medical device MMDR reforms

Semelhante a Kyrgyzstan META data disclosure challenges

Medicines Transparency in JordanMeTApresents

Legal barriers to better use of health data to deliver pharmaceutical innovationOffice of Health Economics

MeTA and data disclosureMeTApresents

Presentation: Pharmacovigilance – a regulator’s perspective TGA Australia

Siobhan gaynor patientclinicalresearchtalkdec15ipposi

Concept and structure of MeTAMeTApresents

STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...Canadian Organization for Rare Disorders

Updates from the Pharmacovigilance and Special Access Branch TGA Australia

Presentation: Updates from the Pharmacovigilance and Special Access BranchTGA Australia

TGA Presentation: Biologicals framework updatesTGA Australia

Presentation: Medicines shortages - Changes to the communication and manageme...TGA Australia

METHODS OF POST MARKETING SURVEILLANCEDr Arathy R Nath

Presentation: Pharmacovigilance requirements inspected and example findingsTGA Australia

Presentation: Hints and Tips for Acceptance of your Prescription Medicines Su...TGA Australia

PharmacovigilanceNiraj Bartaula

0107 Jan Geissler - How drug development works and elements of trial protocolsWorkgroup of European Cancer Patient Advocacy Networks

Cathy parker the orphan drug frameworkCanadian Organization for Rare Disorders

systematic approach in answering Drug queries.pptxDrpradeepthi

MeTA Assessment ToolboxMeTApresents

عرض تقديمي دعائي عصري أبيض وأرجواني.pptxOmarAlqadi5

Semelhante a Kyrgyzstan META data disclosure challenges (20)

Medicines Transparency in Jordan

Legal barriers to better use of health data to deliver pharmaceutical innovation

MeTA and data disclosure

Presentation: Pharmacovigilance – a regulator’s perspective

Siobhan gaynor patientclinicalresearchtalkdec15

Concept and structure of MeTA

STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...

Updates from the Pharmacovigilance and Special Access Branch

Presentation: Updates from the Pharmacovigilance and Special Access Branch

TGA Presentation: Biologicals framework updates

Presentation: Medicines shortages - Changes to the communication and manageme...

METHODS OF POST MARKETING SURVEILLANCE

Presentation: Pharmacovigilance requirements inspected and example findings

Presentation: Hints and Tips for Acceptance of your Prescription Medicines Su...

Pharmacovigilance

0107 Jan Geissler - How drug development works and elements of trial protocols

Cathy parker the orphan drug framework

systematic approach in answering Drug queries.pptx

MeTA Assessment Toolbox

عرض تقديمي دعائي عصري أبيض وأرجواني.pptx

Mais de MeTApresents

MeTA financial systems and reportingMeTApresents

Priorities and milestones – The PhilippinesMeTApresents

MeTA priorities and milestones in PeruMeTApresents

Jordan National Priorities And MilestonesMeTApresents

MeTA introductionMeTApresents

MeTA Core PrinciplesMeTApresents

MeTA priorities and milestones in ZambiaMeTApresents

Data disclosure in ZambiaMeTApresents

MeTA priorities and milestones in UgandaMeTApresents

MeTA programme implementation, monitoring and reportingMeTApresents

MeTA pilot countries support needs and recommendationsMeTApresents

Strengthening multi-stakeholder processesMeTApresents

Data disclosure in JordanMeTApresents

MeTA International priorities and milestonesMeTApresents

MeTA priorities and milestones in GhanaMeTApresents

Data disclosure in GhanaMeTApresents

MeTA evaluation and futureMeTApresents

MeTA country guidance noteMeTApresents

Data disclosure in GhanaMeTApresents

MeTA MSP workshop: Follow up activities - World CafeMeTApresents

Mais de MeTApresents (20)

MeTA financial systems and reporting

Priorities and milestones – The Philippines

MeTA priorities and milestones in Peru

Jordan National Priorities And Milestones

MeTA introduction

MeTA Core Principles

MeTA priorities and milestones in Zambia

Data disclosure in Zambia

MeTA priorities and milestones in Uganda

MeTA programme implementation, monitoring and reporting

MeTA pilot countries support needs and recommendations

Strengthening multi-stakeholder processes

Data disclosure in Jordan

MeTA International priorities and milestones

MeTA priorities and milestones in Ghana

Data disclosure in Ghana

MeTA evaluation and future

MeTA country guidance note

Data disclosure in Ghana

MeTA MSP workshop: Follow up activities - World Cafe

Último

Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Modelssonalikaur4

Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts

Call Girls Thane Just Call 9910780858 Get High Class Call Girls Servicesonalikaur4

Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...narwatsonia7

Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta

call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar

Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7

97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort

Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7

Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7

Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7

Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7

High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha

Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7

Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...narwatsonia7

Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7

Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics

VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4

Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7

Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD